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Objective: To determine whether screening, brief intervention, and referral for treatment 
can reduce the prevalence of tobacco use in rural and semi-rural settings.
Method: Design and participants: A non-randomized clinical trial with assessments at 
baseline and post-intervention assessments at 3 and 6 months was conducted in a 
rural and semi-rural district in South-West of Nigeria. A representative sample of 1203 
persons consented to the study and had alcohol, smoking, and substance involvement 
screening test (ASSIST) administered to them by trained community health-care exten-
sion workers between October 2010 and April 2011. Follow-up participation was more 
than 99% at all points. Intervention: Participants received a single ASSIST-linked brief 
intervention (BI) and referral for treatment (RT) at entry, and a booster ASSIST BI and RT 
at 3 months. Main outcomes and measures: The primary outcome was self-reported 
scores on ASSIST.
results: At baseline, out of 1203 respondents, lifetime prevalence and current prev-
alence of any tobacco products were 405 (33.7%) and 248 (20.6%), respectively. Of 
the current users, on the ASSIST, 79 (31.9%) scored 0–3 (low health risk), 130 (52.4%) 
scored 4–26 (moderate risk), and 39 (15.7%) scored 27+ (high risk). At 3 months, out 
of 1199 respondents, prevalence of current users was 199 (16.5%) and out of 1195 
respondents, was 169 (14.1%) at 6 months. Prevalence of tobacco use reduced signifi-
cantly at 3 months Z = −3.1, p = 0.01 and at 6 months when compared with baseline 
Z = 4.2, p = 0.001, but not at 6 months compared with at 3 months, Z = 2.1, p = 0.09. 
Multivariate analysis revealed that age at initiation of tobacco use, gender, marital status, 
setting of dwelling, and socioeconomic status were the only variables that were associ-
ated with current tobacco use at baseline, 3 and 6 months.
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conclusion: A one-time BI with a booster at 3 months had a significant effect on tobacco 
use in persons living in community settings. This finding suggests a need for promoting the 
adoption of this intervention for tobacco use in rural and semi-rural community settings.
Keywords: screening, brief intervention, community, tobacco, smoking
inTrODUcTiOn
While globalization of the use of cigarette and other products of 
tobacco is a major threat to public health worldwide (1, 2), studies 
have noted the decline in tobacco use in high-income countries 
and an increase in use in middle- and low-income countries 
(3, 4). For instance, Guindon and Boisclair reported that from 
1970 to 2000, per capita cigarette consumption reduced by 14% 
in the Western world while it increased by 46% in the developing 
nations (3).
The growth of cigarette use in developing countries might 
be linked to the marketing efforts of tobacco companies, loose 
restrictions of tobacco control policies (5), and poor surveillance 
of smoking prevalence in these countries (3, 6, 7). For instance, in 
Nigeria, cigarette imports have increased over the years from 20 
million sticks in 1970, to 198 million in 1990, and 2966 in 2000 
(8). In addition, Nigeria ranks third among the largest tobacco 
markets in Africa after Egypt and South Africa. Despite this 
increase, the lifetime prevalence of tobacco use is 17% (9), and the 
overall prevalence of tobacco use in Nigeria is 8.9% (10), which 
is comparatively low compared with the US prevalence rate of 
16.8% (11). Thus, Nigeria appears to be in early stages of cigarette 
epidemic. Estimate of deaths from smoking-attributed causes in 
sub-Saharan Africa reaches only 5–7% for men and 1–2% for 
women (12). Yet, this status and the consequences of cigarette 
use are not likely to respond to a quick change, partly due to weak 
government restrictions on tobacco use or sales.
In Nigeria, the infrastructure for tobacco control is poor despite 
the country’s ratification of the WHO Framework Convention on 
Tobacco Control (13). Nigeria has not implemented regulations 
such as age verification for sales, sales to minors, misleading 
information on packaging, the amount of tar and nicotine, 
product constituents as confidential information, product con-
stituents as public information, constituent disclosure by brand, 
and constituent disclosure by aggregate, smoking in restaurants, 
nightclubs, and bars (14). Specifically, the Tobacco Control Bill, 
which was passed in the National Assembly about a decade ago, 
was yet to be adopted (15). Hence, the unbridled widespread use 
of tobacco in Nigeria may jeopardize future improvements in 
longevity that could be gained by curbing the impact of AIDS, 
starvation, and violence (16). Of note is the fact that attributable 
mortality to tobacco use is rising and if the current epidemic 
continues, more than 70% of these deaths are expected to occur 
in developing countries including Nigeria (17).
Therefore, there is a need to find other strategies that might 
work while efforts are ongoing to firm up tobacco restrictions at 
the government level in Nigeria. Screening, brief intervention, 
and referral for treatment (SBIRT) is a public health model that 
is used to screen for substance abuse and also for the delivery of 
low-intensity substance abuse treatments in a primary health-care 
setting (18). SBIRT for unhealthy drug use has been described in 
the scientific literature for over 50 years (19), and there has been 
relatively robust evidence for its effectiveness for substance use, 
particularly unhealthy alcohol use (20). However, some studies 
have noted that evidence for the effectiveness of SBIRT is much 
more limited for other drug use and in settings other than pri-
mary care (21).
In the Western world, the provision of SBIRT as a form of 
smoking cessation intervention is generally toward treatment 
seeking smokers (22). In developing countries such as Nigeria, 
where the majority live in rural settings, and access to medical 
care is limited to urban centers, smoking cessation treatment may 
not be offered until tobacco-related disease is detected or until 
the smoker expresses interest in quitting. Within this context, 
SBIRT will be particularly well suited for non-treatment seek-
ing smokers of cigarette. In other words, while much attention 
has focused on primary care as a setting to promote smoking 
cessation, community settings could be uniquely positioned for 
tobacco intervention efforts in resource poor settings, such as 
Nigeria, where access to hospital care is limited. However, given 
the studies that reported inefficacy or mixed results of SBIRT, 
SBIRT intervention should not be taken as universally effective.
Therefore, in the developing countries, such as Nigeria, where 
it has not been evaluated before, there is a need for evaluative 
studies to guide policy and interventions. The current investiga-
tion was a single arm study designed to examine the prevalence of 
tobacco use and evaluate the effectiveness of SBIRT in semi-rural 
and rural communities. We hypothesized that participants who 




Nigeria is a developing country in West Africa. Nigeria was 
ranked 191st among 194 member states of the World Health 
Organization in terms of overall health attainment. The study 
site was in Ibadan, Oyo State. Ibadan is the capital of Oyo state, 
Nigeria, and it is the third largest city in Nigeria. The city is located 
in the southwestern part of the country. It has a population of over 
3.5 million people and 11 local government areas (23).
Ethical approval for the study was obtained from the Ethical 
Review Committee of the Ministry of Health, Oyo State, Nigeria. 
Assent was obtained from participants between 15 and 18 years 
and informed consent from 18 years and above.
study Design
A systematic stratified sampling method was used to select two 
local governments in Ibadan between October 2010 and April 
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2011. In the first stage, all 11 LGA were classified into rural or 
semi-rural based on government fund allocation. In the second 
stage, one local government was randomly chosen from each 
group, and in the third stage, four enumeration areas were 
systematically selected as clusters. The fourth stage involved the 
mapping and numbering of all buildings in each of the selected 
enumeration areas. All households within each building were 
serially listed in the Form specifically designed for the purpose. 
After getting the list of the households, simple random sampling 
was used to identify the households that fell within the sample. 
Regular households were distinguished from institutional house-
holds. All eligible respondents, who were 15  years and above 
in each household, were selected and were interviewed using 
the questionnaires including alcohol, smoking, and substance 
involvement screening test (ASSIST) after they gave consent/
assent. The inclusion criteria for the study were both male and 
female tobacco users of age ≥15 years and permanent residents 
of study areas. The exclusion criteria were non-users of tobacco of 
age <15 years, not willing to get tobacco cessation intervention, 
and not a permanent resident of the study areas.
intervention Training in sBirT  
and Quality control
To increase the possibility of an effect while observing a real-
world feasibility in a resource poor setting, brief interventionists 
were recruited from community health-care extension workers 
(CHEWs) in participating primary health-care clinics (n = 18). 
The CHEWs had been involved with previous surveys and agreed 
to adhere to the study protocol. All interventionists were trained 
by Victor Olufolahan Lasebikan using a group workshop followed 
by individual feedback on audio-taped role plays with up to five 
standardized patients over the course of 5 weeks (24). Treatment 
fidelity was assessed by scoring of 5 audio-taped role plays using 
Motivational Interviewing Treatment Integrity coding system 
(MITI 3.0) (25). Mean global scores ranged from 4.35 to 4.64 
which were well above the proficiency benchmark of 4.0. All 
interventionists met basic motivational interviewing proficiency 
training goals on at least one practice role play.
A 3 days of debriefing and review of all protocols were carried 
out, after a pilot survey in each of the study local governments. 
Each interviewer had conducted two pilot interviews in the 
field. All questionnaires were reviewed for completeness by field 
coordinators. The pilot studies were carried out in a ward unit as 
enumerated during the National population census in each of the 
study local governments. This was to assess applicability of the 
instruments of data collection and research adherence.
instruments
 1. A sociodemographic pro forma was specifically designed for 
this study to elicit the sociodemographic characteristics of 
the respondents. The questionnaire contained items such as 
age, age at initiation, frequency of tobacco use, marital status, 
socioeconomic class, and years of education. For the purpose 
of this study, tobacco use was synonymous with smoking.
 2. The ASSIST was developed mainly to screen for drug use, 
but can be used for other substances, including alcohol and 
tobacco as well, particularly in high prevalence settings (26). 
The ASSIST is an eight-item instrument that screens for use 
of all substance types [tobacco products, alcohol, cannabis, 
cocaine, amphetamine-type stimulants (ATS), sedatives, 
hallucinogens, inhalants, opioids, and “other” drugs] and 
determines a risk score (“lower,” “moderate,” or “high”) for 
each substance (27). The risk scores are generated from item 
questions 2–7 for tobacco. The responses are scored from 0 
to 6 based on the frequency of use of the specific substance. 
The risk scores are recorded on the ASSIST feedback report 
card which is used to give personalized feedback to clients by 
presenting them with the scores that they have obtained, and 
the associated health problems related to their level of risk. 
Asking clients if they are interested in viewing their scores 
allows the health worker to commence a discussion (brief 
intervention) with the client in a non-confrontational way 
and has been found to be a successful way of getting clients 
at moderate risk, in particular, to change their substance use 
(27). Scoring: for tobacco use, 0–3 (low risk), 4–26 (moderate 
risk), and 27+ (high risk). This instrument was used to score a 
representative sample of 1203 adolescents and adults (15 years 
and over) for the risk of hazardous and harmful consequences 
of tobacco and other substances.
The lifetime prevalence of tobacco use was obtained from Q1: 
“In your life, which of the following substances have you ever 
used (non-medical use only)?” We obtained current prevalence 
of tobacco use from Q2: “In the past 3 months how often have you 
used the substances you mentioned?” Responses were “never,” 
“once or twice,” “monthly,” “weekly,” and “daily/almost daily.” For 
the purpose of this study, use in the past 3 months was considered 
to be current use.
Procedure
For those who screened positive for unhealthy tobacco use, 
ASSIST-Linked SBIRT was conducted as appropriate.
Intervention
The intervention for those who had a low risk of tobacco use (score 
of 0–3) was general health advice, for those with moderate risk 
(score of 4–26), was brief intervention and a leaflet containing 
information about tobacco use, and those with high risk tobacco 
use (score of 27+) had brief intervention, information leaflet on 
tobacco use and were offered referral to a specialist hospital for 
further assessment and treatment.
The information leaflet about tobacco use contained facts 
about the consequences of unhealthy tobacco use, tips for reduc-
ing the risk of tobacco-related harm, and sources of support for 
tobacco problems (e.g., contact details of services available in 
the local health district). Respondents, who had an unhealthy 
tobacco use, were followed up and reassessed at 3 and 6 months.
A booster brief intervention and referral to treatment was 
given at 3  months. Interviewers used eight anchor community 
members to maintain contact with members of the household, 
while interviewers maintained contact with these anchor persons 
in between interviews. Tobacco use in this study is defined as 
cigarette smoking.







% χ2 df p
age (years)
<25 508 122 28.0 8.8 (5) 0.1
25–34 256 54 21.1
35–44 158 25 15.8
45–54 120 22 18.3
55–64 111 17 15.3
>64 50 8 16.0
age at initiation (years)
<25 508 239 47.0 372.2 <0.001
>25 695 9 1.3
gender
Male 623 181 29.1 55.2 (1) <0.01
Female 580 67 11.6
setting
Urban 487 78 16.0 10.1 (1) <0.01
Rural 716 170 23.8
Marital status
Married 796 143 16.0 9.6 (1) 0.002
Not married 407 105 26.0
education (years)
0 119 26 21.8 1.2 (3) 0.7
1–6 431 91 21.1
7–12 570 111 19.5
>12 83 20 24.1
socioeconomic groupa
Low 513 173 33.7 11.1 (3) <0.001BS
Low average 598 68 11.4
High average 63 6 9.5
High 29 1 3.4
aBased on monthly wages in local currency: low – <18,500 Naira (government 
minimum wage), low average – 18,500–75,000 Naira; high average – 75,000–150,000 
Naira, high – >150,000 Naira.
BS, significant following Bonferroni correction.
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Evaluation of the Intervention
The outcome of the intervention was assessed by evaluating 
changes in the mean number of cigarettes smoked/day at 3 
and 6 months post-intervention and the mean ASSIST scores 
at 3 and 6 months. This is in accordance with the application 
of ASSIST instrument in following up clients over time. The 
use of mean ASSIST score has been specifically found to be 
highly valuable in assessing changes in ASSIST scores over 
time (28).
Data analysis
For our univariate analysis, the association between sociode-
mographic variables and current tobacco use was determined 
using the Pearson’s chi square statistics. Using the current 
prevalence rates at baseline, the Wilcoxon Signed-Rank test and 
paired t-test were used to determine significant changes in the 
proportion of tobacco users and the mean ASSIST scores at 3 and 
6 months. For categorical data, all Chi squares were Yates cor-
rected for all two levels comparisons and Bonferroni corrected 
for comparisons more than two levels. Following Bonferroni 
corrections, multiple pairwise comparisons were carried out 
using Chi square statistics.
Multivariate analyses were carried out using variables that 
were significant during univariate analysis to determine the 
association with tobacco use. This was carried out using binary 
logistic regression. To facilitate the interpretation of odds ratio, a 
reference category was always chosen for the independent vari-
ables with which other independent variables could be compared 
with tobacco use. This was done for the data at baseline, at 3 and 
6 months. Analysis of data was carried out using the Statistical 
Program for Social Studies SPSS version 13.0.
resUlTs
enrollment and screening
The interventionists identified a total of 1329 community dwell-
ers as potentially eligible, of whom 1213 underwent screening. Of 
them, 10 were excluded because of the presence of severe general 
medical conditions, giving a response rate of 91.3%. The final 
analysis was carried out for 1203 questionnaires at baseline. At 
3 months, analysis was carried out on 1199 respondents and on 
1195 participants at 6 months.
Participants’ characteristics
The mean age of respondents at baseline was 24.45 ± 9.23 years, 
51.8% were males, 66.2% were married, 47.4% had at least some 
secondary education, and 49.7% were of low-average socioeco-
nomic group. Current tobacco use was more significant among 
males, χ2 = 55.2, p < 0.01, unmarried, χ2 = 9.6, p = 0.002, and 
low socioeconomic group, χ2 = 11.1, p < 0.001 (Table 1). Mean 
age of initiation into smoking was 17.83 (3.23) years.
intervention effects
At baseline, overall lifetime prevalence and current prevalence 
of any tobacco products was 33.7 and 20.6%, respectively. At 
3 months, prevalence of current tobacco use was 16.5% and was 
14.1% at 6 months. The prevalence of tobacco use reduced signifi-
cantly at 3 months Z = −3.1, p = 0.01 (RR: 0.009 < 0.04 > 0.071) 
and at 6 months when compared with baseline Z = −4.2, p = 0.001 
(RR: 0.034 < 0.065 > 0.095), but not at 6 months compared with 
at 3 months, Z = −2.1, p = 0.09 (RR: −0.004 < 0.025 > 0.0536) 
(Table 2).
Of the current users, 79 (31.9%) scored between 0 and 3 on the 
ASSIST (at low health risk), 130 (52.4%) scored between 4 and 26 
on the ASSIST (at moderate health risk), and 39 (15.7%) scored 
27+ on the ASSIST (at high health risk). The mean ASSIST score 
significantly reduced at 3 and 6 months, compared with baseline 
measure, t = 5.0, p < 0.001 and t = −5.7, p < 0.001, respectively 
(Table 2).
referral to Treatment and engagement
Thirty-nine (15.7%) participants had ASSIST scores ≥27 and 
were referred for treatment. At 3 months follow-up, 21 (10.6%) 
participants were referred for treatment and 20 (11.8%) at 
6 months follow-up (Table 2).
TaBle 2 | Tobacco use and associated factors: prevalence and effect of brief intervention.






Baseline vs.  
3 months
Baseline vs.  
6 months
3 vs. 6 months
statistics p statistics p statistics p
Lifetime prevalence, n (%) 405 (33.7) 405 (33.7) 405 (33.9)
Current use, n (%) 248 (20.6) 199 (16.5) 169 (14.1) −3.1Z, p = 0.01 −4.2Z, p = 0.001 −2.1Z, p = 0.09
Male, n (%) 230 (19.1) 192 (16.0) 164 (13.7)
Low risk tobacco usea, n (%) 79 (31.9) 114 (57.3) 107 (63.4) 7.4Z, p < 0.001 6.6Z, p < 0.001 1.3Z, p = 0.89
Moderate risk tobacco usea, n (%) 130 (52.4) 64 (31.7) 42 (24.9) −8.9Z, p < 0.001 −10.1Z, p < 0.001 −3.5, p < 0.01
High risk tobacco usea, n (%) 39 (15.7) 21 (10.6) 20 (11.8) −5.8Z, p = 0.001 −5.7Z, p = 0.001 1.1Z, p = 0.99
High risk tobacco + moderate or high risk 
alcohol usea, n (%)
36 (92.3) 16 (76.2) 13 (66.6) −8.1Z, p < 0.001 −8.8Z, p < 0.001 1.2Z, p = 0.88
Moderate risk tobacco + moderate or high 
risk alcohola, n (%)
65 (50.0) 27 (42.2) 16 (38.1) −5.2Z, p < 0.001 −5.5Z, p < 0.001 1.3Z, p = 0.89
Mean ASSIST score (SD) 20.11 (5.56) 16.12 (3.23) 15.45 (3.1) −5.0t, p < 0.001 −5.7t, p < 0.001 1.2t, p = 0.96
Mean (SD) daily cigarette smoking 23.76 ± 13.53 18.56 ± 10.09 17.98 ± 9.76 −7.85, p < 0.001 −19.8, p < 0.001 −0.8t, p = 0.79
aLevel of risk was based on ASSIST scores.
Z, Wilcoxon Signed-Rank Test; t, paired t-test.
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Of the 39 current users at high risk of health problems, 36 
(92.3%) were also at either moderate or high risk of alcohol. Sixty-
five (50.0%) of the 130 current users at moderate risk of health 
problems were either at high or moderate risk of health problems 
from alcohol (Table 2).
There was a significant reduction in the mean number of 
cigarettes smoked per day at 3 months compared with baseline, 
t = −7.85, p < 0.001 and also at 6 months compared with baseline, 
t = −19.8, p < 0.001 (Table 2).
At 3 months, a significantly higher proportion of respondents 
whose age of initiation into tobacco use was <25  years were 
current users compared with those whose age at initiation into 
tobacco use was ≥25 years, χ2 = 309.4, p < 0.001. Also, a higher 
proportion of respondents, who were of male gender were cur-
rent tobacco users compared with the female gender, χ2 = 200.0, 
p < 0.001. A significantly higher proportion of respondents who 
were rural dwellers were current tobacco users compared with 
the semi-rural dwellers, χ2 =  27.4, p <  0.001. A significantly 
higher proportion of respondents who were unmarried were 
current tobacco users compared with those who were married, 
χ2 = 27.1, p < 0.001. There was also a significant difference in 
the prevalence of current tobacco use across the socioeconomic 
status of these respondents χ2 = 8.01, p = 0.005. Post hoc multiple 
comparisons show that this difference was due to a higher cur-
rent tobacco use among the low socioeconomic group, compared 
with the low average group χ2 = 28.2, p < 0.001, on the one hand, 
a higher current tobacco use among the low socioeconomic 
group compared with the high average group FE p < 0.001 and a 
higher current tobacco use among the low socioeconomic group 
compared with the high socioeconomic group FE p < 0.001, on 
the other hand.
At 6 months, a significantly higher proportion of respondents 
whose age at initiation into tobacco use was <25  years were 
current users compared with those whose age at initiation into 
tobacco use was ≥25 years, χ2 = 265.1, p < 0.001. Also, a higher 
proportion of respondents who were of male gender were cur-
rent tobacco users compared with the female gender, χ2 = 160.0, 
p < 0.001. A significantly higher proportion of respondents who 
were rural dwellers were current tobacco users compared with 
the semi-rural dwellers, χ2 =  48.2, p <  0.001. A significantly 
higher proportion of respondents who were unmarried were 
current tobacco users compared with those who were married, 
χ2 = 52.7, p < 0.001. There was also a significant difference in 
the prevalence of current tobacco use across the socioeconomic 
status of these respondents χ2 = 8.2, p = 0.004. Post hoc multiple 
comparisons show that this was due to a higher current tobacco 
use among the low socioeconomic group compared with the low 
average group χ2 = 59.3, p < 0.001, on the one hand, a higher cur-
rent tobacco user among the low socioeconomic group compared 
with the high average group FE p < 0.001 and a higher current 
tobacco user among the low socioeconomic group compared 
with the high socioeconomic group FE p < 0.001, on the other 
hand (Table 3).
Multivariate analysis reveals that at baseline, significant fac-
tors that remained associated with current tobacco use were age 
at initiation into tobacco use OR = 0.03, 95% CI (0.001–0.05), 
p < 0.001, female gender OR = 0.28, 95% CI (0.18–0.46), p < 0.01, 
being unmarried OR = 2.96, 95% CI (1.12–5.23), p < 0.01, high 
socioeconomic status OR = 0.32, 95% CI (0.19–0.59), p = 0.001, 
high average socioeconomic status, OR = 0.69, 95% CI (0.23–0.71), 
p = 0.003, low average socioeconomic status, OR = 0.65, 95% CI 
(0.18 = 0.78), p = 0.01, and being a rural dweller OR = 3.05, 95% 
CI (2.00–4.14), p = 0.001.
At 3  months, significant factors that remained associated 
with current tobacco use were age at initiation into tobacco 
use OR = 0.04, 95% CI (0.003–0.07), p < 0.001, female gender 
OR =  0.18, 95% CI (0.009–0.37), p <  0.001, being unmarried 
OR =  2.07, 95% CI (1.28–4.22), p <  0.01, high socioeconomic 
status OR =  0.31, 95% CI (0.002–0.37), p =  0.001, high aver-
age socioeconomic status, OR  =  0.69, 95% CI (0.35–0.73), 
p = 0.002, low average socioeconomic status, OR = 0.54, 95% CI 
(0.17–0.61), p = 0.006, and being a rural dweller OR = 2.83, 95% 
CI (1.54–4.02), p = 0.002.
At 6  months, significant factors that remained associated 
with current tobacco use were age at initiation into tobacco 
use OR = 0.02, 95% CI (0.003–0.04), p < 0.001, female gender 
TaBle 3 | sociodemographic correlates of tobacco use.
3 months 6 months
Variation Total (N = 1199) User (n = 199) % χ2 p Total (N = 1195) User (n = 169) % χ2 p
age (years)
<25 507 110 21.7 2.9 0.09 506 102 20.2 3.0 0.08
25–34 255 44 17.3 254 39 15.4
35–44 157 17 10.8 156 12 7.7
45–54 119 14 11.8 118 9 7.6
55–64 111 10 9.0 111 5 4.5
>64 50 4 8.0 50 2 4.0
age at initiation (years)
<25 479 191 39.9 309.4 <0.001 477 164 34.4 265.1 <0.001
≥25 720 8 1.1 718 5 0.7
gender
Male 604 192 29.0 200.0 <0.001 602 164 27.2 160.0 <0.001
Female 595 7 4.0 593 5 0.8
setting
Semi-rural 479 46 9.6 27.4 <0.001 477 26 5.4 48.2 <0.001
Rural 720 153 21.2 718 143 19.9
Marital status
Married 791 99 12.5 27.1 <0.001 790 70 8.9 52.7 <0.001
Not married 408 100 24.5 405 99 24.4
education (years)
0 118 20 20.3 1.2 0.7 116 24 20.7 0.5 0.4
1–6 431 80 18.6 431 65 15.1
7–12 567 95 16.8 566 68 12.0
>12 83 10 12.0 82 9 11.0
socioeconomic groupa
Low 511 144 28.1 8.01 0.005BS 511 134 26.2 8.2 0.004BS
Low average 596 51 8.6 596 33 5.5
High average 62 3 4.8 62 2 3.2
High 29 1 3.4 25 1 4.0
aBased on monthly wages in local currency: low – <18,500 Naira (government minimum wage), low average – 18,500–75,000 Naira; high average – 75,000–150,000 Naira, 
high – >150,000 Naira.
BS, significant following Bonferroni correction.
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OR =  0.12, 95% CI (0.03–0.29), p <  0.001, being unmarried 
OR  =  3.54, 95% CI (2.02–7.423), p  =  0.001, high socioeco-
nomic status OR = 0.32, 95% CI (0.002–0.57), p = 0.001, high 
average socioeconomic status, OR =  0.57, 95% CI (0.35–0.73), 
p = 0.002, low average socioeconomic status, OR = 0.63, 95% CI 
(0.49–0.81), p = 0.005, and being a rural dweller OR = 2.99, 95% 
CI (1.03–8.23), p < 0.001 (Table 4).
DiscUssiOn
This study is most probably the first in sub-Saharan Africa that 
aimed to determine in semi-rural and rural community set-
tings, the prevalence and correlates of tobacco use, as well as the 
effectiveness of ASSIST-Linked SBIRT in unhealthy tobacco users 
among these communities dwellers.
The lifetime prevalence of tobacco use among our participants 
was 33.7% and this is not much lower than the 44% lifetime use 
among those 15 years and older in Canada (29). We also found 
that the current prevalence of tobacco use was 20.6% at baseline. 
This is higher than the 17% prevalence reported among Nigerian 
adults in 2007 in a nationally representative sample (9), but is 
similar to the 16 and 20% prevalence of tobacco use among 
persons who were 15 years and above in Canada and America, 
respectively. It is also similar to the overall tobacco use prevalence 
of 21% in India (30). However, compared with our estimates, the 
2012 Global Adult tobacco Survey (GATS) that was conducted 
in 16 countries found higher current tobacco use prevalence in 
North America, Europe, and South Asia (31). Nonetheless, our 
finding suggests that tobacco use might be assuming epidemic 
proportions in people who live in rural and semi-rural settings 
in Nigeria.
Another key finding in our study is the group of correlates 
of tobacco use among current users. Those who used tobacco 
were more likely to have started around 17 years of age, to be 
males, unmarried, of low socioeconomic status and live in a 
rural setting. With respect to the age at initiation of tobacco use, 
this is similar to the age at smoking initiation that is before the 
age of 18 years in Western countries (32). We acknowledge that 
the average age at tobacco initiation varies by country, income, 
education, and age cohort (31, 33–35). In addition, we note that 
differences in age at initiation by country may reflect variation 
in stages of tobacco use epidemic between countries or the 
TaBle 4 | Odd ratio for current tobacco use.
Baseline 3 months 6 months
Variation Or 95% ci p Or 95% ci p Or 95% ci p
age at initiation (years)
<25 1 1 1
>25 0.03 0.001–0.05 <0.001 0.04 0.003–0.07 <0.001 0.02 0.003–0.04 <0.001
gender
Male 1 1 1
Female 0.28 0.18–0.46 <0.01 0.18 0.009–0.37 <0.001 0.12 0.03–0.29 <0.001
Marital status
Married 1 1 1
Not married 2.96 1.12–5.23 <0.01 2.07 1.28–4.22 0.01 3.54 2.02–7.42 0.001
socioeconomic group
Low 1 1 1
Low average 0.65 0.18–0.78 0.01 0.54 0.17–0.61 0.006 0.63 0.49–0.81 0.005
High average 0.69 0.23–0.71 0.003 0.69 0.35–0.73 0.002 0.57 0.35–0.73 0.002
High 0.32 0.19–0.59 0.001 0.31 0.002–0.37 0.001 0.32 0.002–0.57 0.001
setting
Urban 1 1 1
Rural 3.05 2.00–4.14 0.001 2.83 1.54–4.02 0.002 2.99 1.03–8.23 <0.001
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complexity of tobacco control measures implemented (36). We 
cautioned above that tobacco use in the rural and semi-rural set-
tings in Nigeria might be assuming epidemic proportions. In line 
with this, we situate our current finding of lower age at initiation 
of tobacco use as highlighting a significant problem that could 
be faced in the future of the health consequences of tobacco use 
and dependency on tobacco.
From the foregoing, one could justifiably ask “what could make 
youths especially in rural settings use tobacco at an earlier age?” 
Our data deductively serve to guide and stimulate additional 
research. In addition, priority needs to be given to the develop-
ment of country specific tobacco control programs for adolescents 
and youths. Furthermore, given the public health importance of 
tobacco-related diseases such as CVD and other CVD risk factors 
(e.g., diabetes, hypertension) (37, 38), it is critical to track tobacco 
use within specific contexts (i.e., rural vs. semi-rural settings) 
in Nigeria and to characterize tobacco use patterns in terms of 
populations that could be vulnerable to tobacco use.
Concerning other correlates, our study aligns with prior 
research (30, 38–40). In both India and Pakistan, some predictors 
of tobacco use are male gender, low socioeconomic status, and 
rural geographic location (30, 41). We confirm that male gender 
is a correlate of tobacco use in low-income countries, in contrast 
to middle- and high-income countries where the male prepon-
derance is blurring (42). Similar to the male gender contrast, our 
findings as regards the association between tobacco use and rural 
dwelling is in line with low-income countries (43) but dissimilar 
to findings in middle- and high-income countries where tobacco 
use correlates with dwellers in large cities (44). However, our result 
with respect to a positive relationship between tobacco use and 
low socioeconomic status is in agreement with Western findings 
(44) as well as findings from other developing nations (30, 38, 39). 
It is possible that unawareness of the health risks of tobacco use 
might be the factor that ties these associations together. Further 
research is needed to tease out the possible moderating influence 
of lack of information on the health risk of tobacco use.
Our observation of an associated alcohol-related health risk 
among respondents with tobacco-related health risks is illustra-
tive of the co-use of both tobacco and alcohol. Studies have found 
that smokers are much more likely to use alcohol and vice versa 
(45). Also, tobacco and alcohol share a similar psychological 
mechanism as subjective mood altering chemicals that are socially 
learned and are used by some individuals as coping mechanisms 
(46). Moreover, repeated use acts as positive reinforcement (47); 
the pharmacological dependence of nicotine usually increases the 
probability of alcohol use, usually in social settings because of the 
social acceptability of alcohol.
A major finding in this study is that it underscores the useful-
ness and applicability of SBIRT in the hands of CHEW and the 
positive impact of SBIRT delivered through CHEW on tobacco 
use as well as unhealthy use in a semi-rural community setting. 
This current study is important in three ways: (1) it focused on 
tobacco, and not alcohol, (2) SBIRT was deliverable by CHEW 
rather than by clinicians only, and (3) it enrolled people in the 
community with poor access to orthodox medicine and who 
might not seek treatment rather than those who went to the 
hospital or were admitted in emergency settings.
In rural and semi-rural community settings, we investigated 
the usefulness of a single session of brief intervention with a 
booster session in reducing tobacco use. A major finding in this 
assessment was that the rate of tobacco use reduced significantly 
between baseline and 3 and 6 months, respectively. There were 
significant shifts from high risk to moderate and low risk use of 
tobacco.
Our study was limited by a number of factors. First, we did 
not stratify the users into different stages of change. In other 
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words, we could not assess the impact of different stages of 
change in unhealthy tobacco use in our study population. This 
is very relevant considering reports indicating that psychosocial 
interventions, that target behavioral change often do not yield a 
significant effect (48). We therefore recommend further studies 
to explore the possible influence of stages of change in tobacco 
use reduction. Second, we did not assess tobacco cessation and 
tobacco cessation in relation to SBIRT. The main objective of 
SBIRT being cessation from substance use. Future studies are 
required to access tobacco cessation following SBIRT, because 
the reduction in the tobacco use rate does not equate cessation. 
Third, we did not include a control group. This has greatly limited 
the interpretation of the effect of the intervention. Fourth, all our 
analysis was based on self-reports. Future works require, includ-
ing a toxicological screen to their methodology. Fifth, we also 
did not allocate any diagnosis to the tobacco users; therefore, it 
was difficult to determine if the effect of the intervention was on 
sparing users or long-term users.
In conclusion, while tobacco use is reaching epidemic propor-
tions in rural and semi-rural settings in Nigeria and is associated 
with male gender, early age at initiation into use, low socioeco-
nomic status, and living in rural areas, SBIRT promises to have 
implementation potentials in delivering the intervention for the 
reduction of tobacco use and unhealthy tobacco use in semi-rural 
community in Nigeria.
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